Access cutting-edge shift work disorder treatment through this clinical trial at a research site in Cullman. Study-provided care at no cost to qualified participants.
Access shift work disorder specialists in Cullman at no cost
This study follows strict safety protocols and ethical guidelines
All study-related shift work disorder treatment provided free
SUSTAIN (Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder) is a Phase 3, multi-center, randomized, double-blind, placebo-controlled, parallel- group trial to assess the efficacy and safety of solriamfetol in adults with excessive sleepiness associated with shift work disorder (SWD).
Sponsor: Axsome Therapeutics, Inc.
Check if you qualify for this shift work disorder clinical trial in Cullman, AL
If you're searching for shift work disorder treatment options in Cullman, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Cullman research site is actively enrolling participants for this clinical trial. You'll receive care from experienced shift work disorder specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.